Prospective observational study to investigate the risk of hematoma formation in total hip arthroplasty patients receiving rivaroxaban and peripheral nerve block concurrently

Trial Profile

Prospective observational study to investigate the risk of hematoma formation in total hip arthroplasty patients receiving rivaroxaban and peripheral nerve block concurrently

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Dec 2015

At a glance

  • Drugs Rivaroxaban (Primary)
  • Indications Deep vein thrombosis; Pulmonary embolism
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top